{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:02:46Z","timestamp":1790650966692,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ogc.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:53:12Z","timestamp":1749599592000},"page":"493-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Opioid Epidemic and Perinatal Health"],"prefix":"10.1016","volume":"52","author":[{"given":"Suzanne","family":"O\u2019Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cresta","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2025.05.005_bib1","unstructured":"Trost SL, Beauregard J, Njie F, et al, Pregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017-2019, 2022, Centers for Disease Control and Prevention, US Department of Health and Human Services. Available at: https:\/\/www.cdc.gov\/maternal-mortality\/php\/data-research\/mmrc-2017-2019.html (Accessed 4 June 2025)."},{"key":"10.1016\/j.ogc.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","article-title":"Vital signs: prescription opioid pain reliever use during pregnancy \u2014 34 U.S. Jurisdictions, 2019","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib4","first-page":"229","article-title":"Opioids and opioid use disorder in pregnancy","volume":"50","author":"Sanjanwala","year":"2023","journal-title":"Obstetrics and Gynecology Clinics"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007\u20132016","volume":"220","author":"Gemmill","year":"2019","journal-title":"AJOG"},{"issue":"4","key":"10.1016\/j.ogc.2025.05.005_bib6","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014","volume":"141","author":"Winkelman","year":"2018","journal-title":"An Pediatr"},{"key":"10.1016\/j.ogc.2025.05.005_bib7","series-title":"Diagnostic and statistical manual of mental disorders : DSM-5-TR American Psychiatric Association, issuing body. 5th edition, text revision","year":"2022"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib9","article-title":"Implementation of universal screening for substance use in pregnancy in a public healthcare system","volume":"4","author":"White","year":"2024","journal-title":"AJOG Glob Rep"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.whi.2016.12.008","article-title":"Characterization of U.S. State laws requiring health care provider reporting of perinatal substance use","volume":"27","author":"Jarlenski","year":"2017","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ogc.2025.05.005_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1045745","article-title":"Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective","volume":"11","author":"Barber","year":"2023","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ADM.0000000000000843","article-title":"Substance use and utilization of prenatal and postpartum care","volume":"16","author":"Nidey","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.ogc.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11920-019-1110-4","article-title":"Opioid use in pregnancy","volume":"2","author":"Tobon","year":"2019","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41372-021-01206-3","article-title":"Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants","volume":"42","author":"Devlin","year":"2022","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.ogc.2025.05.005_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1891\/NN-2021-0003","article-title":"The Eat, Sleep, Console method: a literature review","volume":"41","author":"Nicholson","year":"2022","journal-title":"Neonatal Netw"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis","volume":"2","author":"Link","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ogc.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2024.04.003","article-title":"Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes","volume":"297","author":"Kanervo","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000005510","article-title":"Naltrexone compared with buprenorphine or methadone in pregnancy: a systematic review","volume":"143","author":"Atluru","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2025.05.005_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112454","article-title":"Factors associated with medications for opioid use disorder (MOUD) treatment success during the pregnancy and postpartum periods: a scoping review","volume":"264","author":"Mburu","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ADM.0000000000001052","article-title":"An integrated care model for pregnant and postpartum individuals receiving medication for opioid use disorder","volume":"17","author":"Ellis","year":"2023","journal-title":"J Addict Med"},{"issue":"24","key":"10.1016\/j.ogc.2025.05.005_bib21","first-page":"01178","article-title":"Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder","volume":"S0002-9378","author":"Jarlenski","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/GCO.0000000000000932","article-title":"Pharmacotherapy for opioid use disorder in pregnancy","volume":"36","author":"Trammel","year":"2024","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.005_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ADM.0000000000001163","article-title":"Survey of buprenorphine low-dose regimens used by healthcare institutions","volume":"17","author":"Hardy","year":"2023","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/ADM.0000000000001042","article-title":"Successful buprenorphine\/naloxone low-dose induction in pregnancy: a case report","volume":"17","author":"Coish","year":"2023","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib25","article-title":"Low-dose buprenorphine initiation during pregnancy: a case report","volume":"4","author":"Reddy","year":"2024","journal-title":"AJOG Glob Rep"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ADM.0000000000001233","article-title":"Low-dose induction of buprenorphine in pregnancy: a case series","volume":"18","author":"Junn","year":"2024","journal-title":"J Addict Med"},{"issue":"10","key":"10.1016\/j.ogc.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/phar.4616","article-title":"Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: a population-based study","volume":"44","author":"Hasan","year":"2024","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamainternmed.2023.6986","article-title":"First trimester use of buprenorphine or methadone and the risk of congenital malformations","volume":"184","author":"Suarez","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ogc.2025.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2019.100075","article-title":"Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome","volume":"2","author":"Lappen","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100582","article-title":"Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder","volume":"4","author":"Abdelwahab","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ogc.2025.05.005_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2024.101423","article-title":"The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain development","volume":"69","author":"Volkow","year":"2024","journal-title":"Dev Cogn Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2025.05.005_bib32","first-page":"17","article-title":"Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"3","author":"Lund","year":"2012","journal-title":"Subst Abuse Rehabil"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000289","article-title":"Medically assisted withdrawal (Detoxification): considering the mother-infant dyad","volume":"11","author":"Jones","year":"2017","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.005_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.jp.7210933","article-title":"Prenatal care reduces the impact of illicit drug use on perinatal outcomes","volume":"23","author":"El-Mohandes","year":"2003","journal-title":"J Perinatol"},{"key":"10.1016\/j.ogc.2025.05.005_bib35","unstructured":"Pregnancy and Substance Use: A Harm Reduction Toolkit. Academy of Perinatal Harm Reduction. Available at: https:\/\/www.perinatalharmreduction.org\/toolkit-pregnancy-substance-use (Accessed 4 June 2025)."},{"key":"10.1016\/j.ogc.2025.05.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108765","article-title":"\u201cYou have to take this medication, but then you get punished for taking it\u201d: lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period","volume":"139","author":"Schiff","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000216466","article-title":"Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment","volume":"15","author":"Winklbaur","year":"2009","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.ogc.2025.05.005_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsat.2014.12.002","article-title":"Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review","volume":"52","author":"Akerman","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ogc.2025.05.005_bib39","series-title":"StatPearls","article-title":"Opioid-induced constipation","author":"Sizar","year":"2023"},{"issue":"12","key":"10.1016\/j.ogc.2025.05.005_bib40","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/jum.15163","article-title":"AIUM practice parameter for the performance of detailed second- and third-trimester diagnostic obstetric ultrasound examinations","volume":"38","year":"2019","journal-title":"J Ultrasound Med"},{"issue":"2","key":"10.1016\/j.ogc.2025.05.005_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ADM.0000000000001087","article-title":"Harm reduction approach to increasing self-reported safe medication storage among pregnant and parenting people receiving opioid use disorder treatment","volume":"17","author":"Grist","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.ogc.2025.05.005_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/SAR.S375652","article-title":"Interventions to support engagement in addiction care postpartum: principles and pitfalls","volume":"14","author":"Mazel","year":"2023","journal-title":"Subst Abuse Rehabil"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2025.05.005_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10995-023-03795-1","article-title":"They will never forget how you made them feel: implementing harm reduction in the perinatal setting","volume":"27","author":"Puccio","year":"2023","journal-title":"Matern Child Health J"},{"issue":"7","key":"10.1016\/j.ogc.2025.05.005_bib44","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hec.4518","article-title":"Prenatal substance use policies and newborn health","volume":"31","author":"Meinhofer","year":"2022","journal-title":"Health Econ"},{"issue":"5","key":"10.1016\/j.ogc.2025.05.005_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/ADM.0000000000000963","article-title":"Postoperative cesarean pain management and opioid use disorder: anticipate the need for higher opioid doses and communicate expectations with patients and the obstetric team","volume":"16","author":"Cleary","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.ogc.2025.05.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.12.006","article-title":"Consensus statement on pain management for pregnant patients with opioid use disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine","author":"Lim","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ogc.2025.05.005_bib48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/bfm.2023.29256.abm","article-title":"Academy of breastfeeding medicine clinical protocol #21: breastfeeding in the setting of substance use and substance use disorder (revised 2023)","volume":"18","author":"Harris","year":"2023","journal-title":"Breastfeed Med"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/ADM.0000000000001118","article-title":"Universal postpartum naloxone provision: a harm reduction quality improvement project","volume":"17","author":"Naliboff","year":"2023","journal-title":"J Addict Med"},{"issue":"3","key":"10.1016\/j.ogc.2025.05.005_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10995-017-2283-2","article-title":"One key Question\u00ae: first things first in reproductive health","volume":"21","author":"Allen","year":"2017","journal-title":"Matern Child Health J"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854525000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854525000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:34:36Z","timestamp":1754339676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854525000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0889854525000221"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2025.05.005","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Opioid Epidemic and Perinatal Health","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}